Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;53(4):551-6.
doi: 10.1002/pbc.22128.

Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia

Joshua E Caron  1 , Kevin R Krull, Marilyn Hockenberry, Neelam Jain, Kris Kaemingk, Ida M Moore
Affiliations

Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia

Joshua E Caron et al. Pediatr Blood Cancer. 2009 Oct.

Abstract

Background: Neurocognitive sequelae following treatment for pediatric acute lymphoblastic leukemia (ALL) has been reported in a significant proportion of survivors, including those treated only with chemotherapy. Early identification of children "at risk" for neurocognitive problems is not yet reliable. Biomarkers of oxidative stress (e.g., oxidated phosphatidylcholine) in cerebral spinal fluid (CSF) have been correlated with intensity of methotrexate (MTX) treatment, suggesting an association with acute central nervous system toxicity.

Procedure: This study examined the association between oxidized CSF phospholipids and executive functions throughout chemotherapy. Measures of oxidative stress and executive functions were examined in 88 children newly diagnosed with ALL. The children were followed over 3 years with neurocognitive testing and parent ratings of executive functions.

Results: Results demonstrated an association between increased oxidative stress following induction and consolidation and decreased executive function 2 years later. Younger age at diagnosis was associated with both an increase in oxidative stress and in executive dysfunction; younger age was associated with poorer ability to organize materials in one's environment (r(48) = 0.28, P < 0.05) and with greater oxidated phosphatidylcholine in CSF at the end of chemotherapy (r(48) = -0.27, P < 0.05). As such, younger age appears to be the most prominent moderator of neurocognitive decline.

Conclusions: These results link functional changes to CSF biomarkers and underscore the importance of monitoring cognitive development in young children treated for ALL. Children with less advanced central nervous system development may be particularly vulnerable to the effects of chemotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Parent ratings on measures of Emotional Control and Working Memory functions from post-consolidation to end of therapy for females and males. Higher scores represent more problematic symptoms.
See this image and copyright information in PMC

References

    1. Gurney JG, Bondy ML. Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 5th ed. Lippincott, Williams, & Wilkins; Philadelphia, PA: 2006. pp. 1–13.
    1. Ries LAG, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute; Bethesda, MD: 1999.
    1. Dickerman JD. The late effects of childhood cancer therapy. Pediatrics. 2007;119(3):554–568. - PubMed
    1. Jankovic M, Brouwers P, Valsecchi MG, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet. 1994344(8917):224–227. - PubMed
    1. Spiegler BJ, Kennedy K, Maze R, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol. 2006;24(24):3858–3864. - PubMed

Publication types